KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Q3 2025 value amounting to 0.16%.

  • Aurinia Pharmaceuticals' Return on Capital Employed rose 2300.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.01% for FY2024, which is 2000.0% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Return on Capital Employed stood at 0.16%, which was up 2300.0% from 0.12% recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.16% during Q3 2025, with a 5-year trough of 0.57% in Q3 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Return on Capital Employed value was 0.19% (recorded in 2023), while the average stood at 0.2%.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Return on Capital Employed plummeted by -1600bps in 2021 and then skyrocketed by 3100bps in 2022.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Return on Capital Employed stood at 0.44% in 2021, then skyrocketed by 42bps to 0.26% in 2022, then increased by 25bps to 0.19% in 2023, then skyrocketed by 95bps to 0.01% in 2024, then skyrocketed by 1639bps to 0.16% in 2025.
  • Its Return on Capital Employed was 0.16% in Q3 2025, compared to 0.12% in Q2 2025 and 0.07% in Q1 2025.